CEO and Director, Zentrum Klinische Studien Halle @ Uniklinikum Halle (Saale)
Juergen Scheele's Education
Albert-Ludwigs-Universität Freiburg im Breisgau
Habilitation (Hämatoonkologie/Pharmakologie)
Eberhard-Karls-Universität Tübingen / University of Tuebingen
Dipl. (Biochemie/Molekularbiologie)
Johannes Gutenberg-Universität Mainz
Bachelor's degree (Chemistry)
Ruprecht-Karls-Universität Heidelberg
Staatsexamen (Humanmedizin)
Ruprecht-Karls-Universität Heidelberg
Dr. med. (Humanmedizin)
UC San Diego
MSc (Chemistry)
UC San Diego
PhD (Chemistry and Biochemistry)
Juergen Scheele's Skills
Residency Hematology/ Oncology and Clinical Pharmacology Uniklinikum Freiburg
Habilitation Freiburg: 2004;
Adjunct Professor Hematology/Oncology and Pharmacology, Freiburg, 2010
Klinische Studien
Onkologie
Klinische Entwicklung
CRO
Pharmaindustrie
Biotechnologie
Biowissenschaften
Juergen Scheele's Summary
Juergen Scheele, based in Freiburg im Breisgau, BW, DE, is currently a Chief Medical Officer and Senior Vice President at Innoplexus AG, bringing experience from previous roles at Merck KGaA, Darmstadt, Germany, F. Hoffmann-La Roche Ltd., Micromet AG and Auron Healthcare Gmbh. Juergen Scheele holds a Habilitation in Hämatoonkologie/Pharmakologie @ Albert-Ludwigs-Universität Freiburg im Breisgau. With a robust skill set that includes Residency Hematology/ Oncology and Clinical Pharmacology Uniklinikum Freiburg, Habilitation Freiburg: 2004;, Adjunct Professor Hematology/Oncology and Pharmacology, Freiburg, 2010, Klinische Studien, Onkologie and more, Juergen Scheele contributes valuable insights to the industry. Juergen Scheele has 3 emails on RocketReach.